Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

If you enjoy travel, nostalgia, or collecting souvenirs, you might overlook a hidden treasure hiding in plain sight: rare coins. Some lesser-known or seemingly ordinary coins — often overlooked by ...

To redeem a link, click on it. Doing so redirects you to the Coin Master app. Note that you’ll need to do this on the same phone, tablet, or other device where you’ve installed the app. Make sure ...

DIBOLL — Council members learned that Diboll has recovered nearly $80,000 in delinquent taxes between July and November, as the city’s longtime collection firm reported Tuesday, while also adopting a ...

FIRST ON FOX: Secretary of the Treasury Scott Bessent scrapped Biden-era coin designs intended to celebrate the 250th anniversary of America’s founding after the Trump administration discovered they ...

In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...

Farran Powell is the managing editor of investing at Forbes Advisor. She was previously the assistant managing editor of investing at U.S. News & World Report. Her work has appeared in numerous ...

Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...

The U.S. Mint is issuing special circulating coins to celebrate the 250th anniversary of American's adoption of the Declaration of Independence. Quarters, dimes and nickels minted during 2026 will ...